JMP Securities Keeps Their Buy Rating on Halozyme (HALO)
In a report released today, Jason Butler from JMP Securities reiterated a Buy rating on Halozyme (HALO – Research Report), with a price target ...
JMP Securities Keeps Their Buy Rating on Solid Biosciences (SLDB)
JMP Securities analyst Silvan Tuerkcan reiterated a Buy rating on Solid Biosciences (SLDB – Research Report) today and set a price target of ...
Digital Realty Trust’s (DLR) “Market Outperform” Rating Reiterated at JMP Securities
JMP Securities restated their market outperform rating on shares of Digital Realty Trust (NYSE:DLR – Free Report) in a ...
JMP Securities Reaffirms “Market Outperform” Rating for Blueprint Medicines (NASDAQ:BPMC)
JMP Securities reiterated their market outperform rating on shares of Blueprint Medicines (NASDAQ:BPMC – Free Report) in a ...
Roku's Growth Surges: Analysts Raise Price Targets As Company Expands Ad Reach
Roku, Inc. (NASDAQ:ROKU) shares are trading higher on Friday. Yesterday, the company reported fourth-quarter losses of 24 ...
JMP Securities maintains $220 target on Digital Realty stock
JMP Securities reiterated its Market Outperform rating on Digital Realty Trust (NYSE:DLR) with a steady price target of ...
JMP Securities maintains Confluent stock with $40 target
JMP Securities analyst reiterated a Market Outperform rating with a $40.00 price target for Confluent Inc (NASDAQ:CFLT), representing potential upside for the $9.87 billion market cap company. The ...
Redwood Trust targets 30% volume growth for Sequoia in 2025 with $2B Aspire platform expansion
Management anticipates a 30% year-over-year increase in Sequoia volumes, targeting a return on capital of approximately 20% for 2025. Aspire's expanded mandate is expected to access a $100 billion ...